InMode Ltd. Ordinary Shares (INMD) is a publicly traded Healthcare sector company. As of May 21, 2026, INMD trades at $14.11 with a market cap of $857.40M and a P/E ratio of 0.00. INMD moved +0.29% today. Year to date, INMD is -7.70%; over the trailing twelve months it is -5.01%. Its 52-week range spans $12.72 to $19.85. Analyst consensus is neutral with an average price target of $15.75. Rallies surfaces INMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
InMode Reports Q4 Device Sales Growth and Shares 2026 Guidance: InMode held its fiscal Q4 earnings call, reporting year-over-year revenue growth driven by increased demand for aesthetic and body contouring devices. Management emphasized margin expansion from operating leverage and shared preliminary 2026 revenue guidance highlighting international market expansions.
| Metric | Value |
|---|---|
| Price | $14.11 |
| Market Cap | $857.40M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.85 |
| 52-Week Low | $12.72 |
| Volume | 64 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
6 analysts cover INMD: 0 strong buy, 1 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $15.75.